A challenging complication following SARS-CoV-2 infection: a case of pulmonary mucormycosis

Severe acute respiratory syndrome coronavirus 2 infection might induce a significant and sustained lymphopenia, increasing the risk of developing opportunistic infections. Mucormycosis is a rare but severe invasive fungal infection, mainly described in immunocompromised patients. The first case of a...

Descripción completa

Detalles Bibliográficos
Autores principales: Pasero, Daniela, Sanna, Silvana, Liperi, Corrado, Piredda, Davide, Branca, Gian Pietro, Casadio, Lorenzo, Simeo, Raffaella, Buselli, Alice, Rizzo, Davide, Bussu, Francesco, Rubino, Salvatore, Terragni, Pierpaolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745708/
https://www.ncbi.nlm.nih.gov/pubmed/33331988
http://dx.doi.org/10.1007/s15010-020-01561-x
_version_ 1783624659119374336
author Pasero, Daniela
Sanna, Silvana
Liperi, Corrado
Piredda, Davide
Branca, Gian Pietro
Casadio, Lorenzo
Simeo, Raffaella
Buselli, Alice
Rizzo, Davide
Bussu, Francesco
Rubino, Salvatore
Terragni, Pierpaolo
author_facet Pasero, Daniela
Sanna, Silvana
Liperi, Corrado
Piredda, Davide
Branca, Gian Pietro
Casadio, Lorenzo
Simeo, Raffaella
Buselli, Alice
Rizzo, Davide
Bussu, Francesco
Rubino, Salvatore
Terragni, Pierpaolo
author_sort Pasero, Daniela
collection PubMed
description Severe acute respiratory syndrome coronavirus 2 infection might induce a significant and sustained lymphopenia, increasing the risk of developing opportunistic infections. Mucormycosis is a rare but severe invasive fungal infection, mainly described in immunocompromised patients. The first case of a patient diagnosed with coronavirus disease (COVID-19) who developed a pulmonary mucormycosis with extensive cavitary lesions is here reported. This case highlights how this new coronavirus might impair the immune response, exposing patients to higher risk of developing opportunistic infections and leading to worse outcomes.
format Online
Article
Text
id pubmed-7745708
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-77457082020-12-18 A challenging complication following SARS-CoV-2 infection: a case of pulmonary mucormycosis Pasero, Daniela Sanna, Silvana Liperi, Corrado Piredda, Davide Branca, Gian Pietro Casadio, Lorenzo Simeo, Raffaella Buselli, Alice Rizzo, Davide Bussu, Francesco Rubino, Salvatore Terragni, Pierpaolo Infection Case Report Severe acute respiratory syndrome coronavirus 2 infection might induce a significant and sustained lymphopenia, increasing the risk of developing opportunistic infections. Mucormycosis is a rare but severe invasive fungal infection, mainly described in immunocompromised patients. The first case of a patient diagnosed with coronavirus disease (COVID-19) who developed a pulmonary mucormycosis with extensive cavitary lesions is here reported. This case highlights how this new coronavirus might impair the immune response, exposing patients to higher risk of developing opportunistic infections and leading to worse outcomes. Springer Berlin Heidelberg 2020-12-17 2021 /pmc/articles/PMC7745708/ /pubmed/33331988 http://dx.doi.org/10.1007/s15010-020-01561-x Text en © The Author(s) 2020 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Case Report
Pasero, Daniela
Sanna, Silvana
Liperi, Corrado
Piredda, Davide
Branca, Gian Pietro
Casadio, Lorenzo
Simeo, Raffaella
Buselli, Alice
Rizzo, Davide
Bussu, Francesco
Rubino, Salvatore
Terragni, Pierpaolo
A challenging complication following SARS-CoV-2 infection: a case of pulmonary mucormycosis
title A challenging complication following SARS-CoV-2 infection: a case of pulmonary mucormycosis
title_full A challenging complication following SARS-CoV-2 infection: a case of pulmonary mucormycosis
title_fullStr A challenging complication following SARS-CoV-2 infection: a case of pulmonary mucormycosis
title_full_unstemmed A challenging complication following SARS-CoV-2 infection: a case of pulmonary mucormycosis
title_short A challenging complication following SARS-CoV-2 infection: a case of pulmonary mucormycosis
title_sort challenging complication following sars-cov-2 infection: a case of pulmonary mucormycosis
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745708/
https://www.ncbi.nlm.nih.gov/pubmed/33331988
http://dx.doi.org/10.1007/s15010-020-01561-x
work_keys_str_mv AT paserodaniela achallengingcomplicationfollowingsarscov2infectionacaseofpulmonarymucormycosis
AT sannasilvana achallengingcomplicationfollowingsarscov2infectionacaseofpulmonarymucormycosis
AT lipericorrado achallengingcomplicationfollowingsarscov2infectionacaseofpulmonarymucormycosis
AT pireddadavide achallengingcomplicationfollowingsarscov2infectionacaseofpulmonarymucormycosis
AT brancagianpietro achallengingcomplicationfollowingsarscov2infectionacaseofpulmonarymucormycosis
AT casadiolorenzo achallengingcomplicationfollowingsarscov2infectionacaseofpulmonarymucormycosis
AT simeoraffaella achallengingcomplicationfollowingsarscov2infectionacaseofpulmonarymucormycosis
AT busellialice achallengingcomplicationfollowingsarscov2infectionacaseofpulmonarymucormycosis
AT rizzodavide achallengingcomplicationfollowingsarscov2infectionacaseofpulmonarymucormycosis
AT bussufrancesco achallengingcomplicationfollowingsarscov2infectionacaseofpulmonarymucormycosis
AT rubinosalvatore achallengingcomplicationfollowingsarscov2infectionacaseofpulmonarymucormycosis
AT terragnipierpaolo achallengingcomplicationfollowingsarscov2infectionacaseofpulmonarymucormycosis
AT paserodaniela challengingcomplicationfollowingsarscov2infectionacaseofpulmonarymucormycosis
AT sannasilvana challengingcomplicationfollowingsarscov2infectionacaseofpulmonarymucormycosis
AT lipericorrado challengingcomplicationfollowingsarscov2infectionacaseofpulmonarymucormycosis
AT pireddadavide challengingcomplicationfollowingsarscov2infectionacaseofpulmonarymucormycosis
AT brancagianpietro challengingcomplicationfollowingsarscov2infectionacaseofpulmonarymucormycosis
AT casadiolorenzo challengingcomplicationfollowingsarscov2infectionacaseofpulmonarymucormycosis
AT simeoraffaella challengingcomplicationfollowingsarscov2infectionacaseofpulmonarymucormycosis
AT busellialice challengingcomplicationfollowingsarscov2infectionacaseofpulmonarymucormycosis
AT rizzodavide challengingcomplicationfollowingsarscov2infectionacaseofpulmonarymucormycosis
AT bussufrancesco challengingcomplicationfollowingsarscov2infectionacaseofpulmonarymucormycosis
AT rubinosalvatore challengingcomplicationfollowingsarscov2infectionacaseofpulmonarymucormycosis
AT terragnipierpaolo challengingcomplicationfollowingsarscov2infectionacaseofpulmonarymucormycosis

Ejemplares similares